Christine Antalik Email

Chief Financial Officer . EndoQuest Robotics

Current Roles

Employees:
114
Revenue:
$0
About
EndoQuest Robotics has developed the Endoluminal Surgical (ELS) System, the world’s first endoluminal robotic surgical system that makes it possible for therapeutic endoscopists and surgeons to perform upper and lower gastrointestinal surgery less-invasively through a trans-oral or trans-anal approach. EndoQuest’s robotic platform combines the flexibility of endoscopy that is able to navigate the curvature of patients’ anatomy with instrumentation that allows the physician to use a conventional two-handed surgical technique. The EndoQuest ELS System has further potential applications in a range of endoluminal surgeries including appendectomy and cholecystectomy that can be performed with no external incisions. For additional information, visit the Company’s website at www.endoquestrobotics.com.\n\nThe ELS System is under development, has not been cleared by the FDA and is not for commercial sale in the United?States.
EndoQuest Robotics Address
9310 Kirby Drive
Houston, TX
USA
EndoQuest Robotics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.